1. Choleretic and hypolipidemic effects of high levels of soluble endoglin in mice. (August 2018) Authors: Dolezelova, E.; Prasnicka, A.; Cermanova, J.; Hroch, M.; Hyspler, R.; Ticha, A.; Pericacho, M.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of body weight reduction on plasma fibroblast growth factor 21 in obese patients with type 1 diabetes mellitus. Issue 1 (July 2015) Authors: Musil, F.; Blaha, V.; Ticha, A.; Hyspler, R.; Haluzik, M.; Lesna, J.; Smahelova, A.; Sobotka, L. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of body weight reduction on plasma fibroblast growth factor 21 in obese patients with type 1 diabetes mellitus. Issue 1 (July 2015) Authors: Musil, F.; Blaha, V.; Ticha, A.; Hyspler, R.; Haluzik, M.; Lesna, J.; Smahelova, A.; Sobotka, L. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High Soluble Endoglin Levels Affect Bile Acids And Cholesterol Metabolism In Mice Liver. (August 2019) Authors: Dolezelova, E.; Prasnicka, A.; Sá, I.C.I.; Hroch, M.; Hyspler, R.; Ticha, A.; Pericacho, M.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. High soluble endoglin levels, do not modulate cholesterol and bile acids metabolism in NASH mouse model. (December 2020) Authors: Igreja E Sá, I.C.; Prasnicka, A.; Lastuvkova, H.; Hroch, M.; Hyspler, R.; Tripská, K.; Vicen, M.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Soluble endoglin as a potential biomarker of nash development, participating in aggravation of nash-related changes in mouse liver. (August 2021) Authors: Igreja Sá, I.C.; Tripká, K.; Lastuvkova, H.; Hroch, M.; Hyspler, R.; Dolezelova, E.; Eissazadeh, S.; Vasinova, M.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SUN-LB314: Albumin Copper Binding Assay as a Predictor of Anastomosis Dehiscence in Patients after Colorectal Surgery. (September 2017) Authors: Hyspler, R.; Ticha, A.; Zaloudkova, L.; Svobodova, I.; Kaska, M.; Zadák, Z. Journal: Clinical nutrition Issue: Volume 36(2017)Supplement 1 Page Start: S170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The inhibition of pancreatic lipase by ursolic acid from natural source. (September 2018) Authors: Hyspler, R.; Ticha, A.; Tomasova, A.; Zadak, Z. Journal: Clinical nutrition Issue: Volume 37(2018)Supplement 1 Page Start: S299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗